Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Outcome of transplantation of highly purified peripheral blood CD34 + cells with T-cell add-back compared with unmanipulated bone marrow or peripheral blood stem cells from HLA-identical sibling donors in patients with first chronic phase chronic myeloid leukemia

Ahmet H. Elmaagacli, Rudolf Peceny, Nina Steckel, Rudolf Trenschel, Hellmut Ottinger, Hans Grosse-Wilde, Ulrich W. Schaefer, Dietrich W. Beelen

Blood (2003) 101 (2): 446–453.

https://doi.org/10.1182/blood-2002-05-1615

Published: 2003

Journal Articles

Improved disease-free–survival after transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical unrelated donors in patients with first chronic phase chronic myeloid leukemia

Ahmet H. Elmaagacli, Semiha Basoglu, Rudolf Peceny, Rudolf Trenschel, Hellmut Ottinger, Andre Lollert, Volker Runde, Hans Grosse-Wilde, Dietrich W. Beelen, Ulrich W. Schaefer

Blood (2002) 99 (4): 1130–1135.

https://doi.org/10.1182/blood.V99.4.1130.h8001130_1130_1135

Published: 2002

Journal Articles

Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell–depleted SCT

Joost W. J. van Esser, Bronno van der Holt, Ellen Meijer, Hubert G. M. Niesters, Rudolf Trenschel, Steven F. T. Thijsen, Anton M. van Loon, Francesco Frassoni, Andrea Bacigalupo, Ulrich W. Schaefer, Albert D. M. E. Osterhaus, Jan Willem Gratama, Bob Löwenberg, Leo F. Verdonck, Jan J. Cornelissen

Blood (2001) 98 (4): 972–978.

https://doi.org/10.1182/blood.V98.4.972

Published: 2001

Journal Articles

The Risk of Residual Molecular and Cytogenetic Disease in Patients With Philadelphia-Chromosome Positive First Chronic Phase Chronic Myelogenous Leukemia Is Reduced After Transplantation of Allogeneic Peripheral Blood Stem Cells Compared With Bone Marrow

Ahmet H. Elmaagacli, Dietrich W. Beelen, Bertram Opalka, Siegfried Seeber, Ulrich W. Schaefer

Blood (1999) 94 (2): 384–389.

https://doi.org/10.1182/blood.V94.2.384

Published: 1999

Journal Articles

Influence of Intestinal Bacterial Decontamination Using Metronidazole and Ciprofloxacin or Ciprofloxacin Alone on the Development of Acute Graft-Versus-Host Disease After Marrow Transplantation in Patients With Hematologic Malignancies: Final Results and Long-Term Follow-Up of an Open-Label Prospective Randomized Trial

Dietrich W. Beelen, Ahmet Elmaagacli, Karl-Dieter Müller, Herbert Hirche, Ulrich W. Schaefer

Blood (1999) 93 (10): 3267–3275.

https://doi.org/10.1182/blood.V93.10.3267.410k22_3267_3275

Published: 1999

Journal Articles

The Adverse Influence of Pretransplant Interferon- (IFN-) on Transplant Outcome After Marrow Transplantation for Chronic Phase Chronic Myelogenous Leukemia Increases With the Duration of IFN- Exposure

Dietrich W. Beelen, Ahmet H. Elmaagacli, Prof. Ulrich W. Schaefer

Blood (1999) 93 (5): 1779–1781.

https://doi.org/10.1182/blood.V93.5.1779

Published: 1999

Journal Articles

Transplantation of Filgrastim-Mobilized Peripheral Blood Stem Cells From HLA-Identical Sibling or Alternative Family Donors in Patients With Hematologic Malignancies: A Prospective Comparison on Clinical Outcome, Immune Reconstitution, and Hematopoietic Chimerism

Dietrich W. Beelen, Helmut D. Ottinger, Ahmet Elmaagacli, Birgit Scheulen, Oliver Basu, Bernhard Kremens, Werner Havers, Hans Grosse-Wilde, Ulrich W. Schaefer

Blood (1997) 90 (12): 4725–4735.

https://doi.org/10.1182/blood.V90.12.4725

Published: 1997

Journal Articles

Detection of AML1/ETO Fusion Transcripts in Patients With t(8; 21) Acute Myeloid Leukemia After Allogeneic Bone Marrow Transplantation or Peripheral Blood Progenitor Cell Transplantation

Ahmet H. Elmaagacli, Dietrich W. Beelen, Jitka Stockova, Susanne Trzensky, Melanie Kroll, Ulrich W. Schaefer, Christina Stein, Bertram Opalka

Blood (1997) 90 (8): 3230–3231.

https://doi.org/10.1182/blood.V90.8.3230

Published: 1997

NARROW

Outcome of transplantation of highly purified peripheral blood CD34 + cells with T-cell add-back compared with unmanipulated bone marrow or peripheral blood stem cells from HLA-identical sibling donors in patients with first chronic phase chronic myeloid leukemia

Improved disease-free–survival after transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical unrelated donors in patients with first chronic phase chronic myeloid leukemia

Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell–depleted SCT

The Risk of Residual Molecular and Cytogenetic Disease in Patients With Philadelphia-Chromosome Positive First Chronic Phase Chronic Myelogenous Leukemia Is Reduced After Transplantation of Allogeneic Peripheral Blood Stem Cells Compared With Bone Marrow

The Adverse Influence of Pretransplant Interferon- (IFN-) on Transplant Outcome After Marrow Transplantation for Chronic Phase Chronic Myelogenous Leukemia Increases With the Duration of IFN- Exposure

Transplantation of Filgrastim-Mobilized Peripheral Blood Stem Cells From HLA-Identical Sibling or Alternative Family Donors in Patients With Hematologic Malignancies: A Prospective Comparison on Clinical Outcome, Immune Reconstitution, and Hematopoietic Chimerism

Detection of AML1/ETO Fusion Transcripts in Patients With t(8; 21) Acute Myeloid Leukemia After Allogeneic Bone Marrow Transplantation or Peripheral Blood Progenitor Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only